Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC.
Lung cancer (Amsterdam, Netherlands)·2022
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.
Disease models & mechanisms·2016